NPI: 1316901937 · COVINGTON, TN 38019 · General Acute Care Hospital · NPI assigned 04/12/2006
Authorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
| Authorized Official | DUCKETT, GREGORY (SR VP/ CLO) |
| Parent Organization | BAPTIST MEMORIAL HEALTH CARE CORP. |
| NPI Enumeration Date | 04/12/2006 |
Other providers sharing the same authorized official: DUCKETT, GREGORY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 46,937 | $2.04M |
| 2019 | 52,567 | $1.62M |
| 2020 | 73,984 | $1.60M |
| 2021 | 100,080 | $2.25M |
| 2022 | 98,292 | $2.38M |
| 2023 | 93,840 | $2.30M |
| 2024 | 57,946 | $1.68M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 22,444 | 19,299 | $3.47M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13,257 | 10,730 | $2.69M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 22,216 | 20,073 | $2.41M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 6,300 | 3,007 | $511K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11,645 | 9,534 | $459K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5,865 | 5,355 | $369K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 67,702 | 44,812 | $360K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 16,077 | 11,541 | $325K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14,629 | 9,898 | $277K |
| 80053 | Comprehensive metabolic panel | 62,041 | 41,707 | $232K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 5,188 | 4,460 | $180K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4,174 | 3,774 | $180K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 23,251 | 10,713 | $178K |
| 96375 | Therapeutic injection; each additional sequential IV push | 9,193 | 6,872 | $173K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,241 | 3,031 | $163K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2,276 | 2,080 | $145K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,067 | 880 | $125K |
| G0378 | Hospital observation service, per hour | 1,188 | 469 | $113K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 9,507 | 8,407 | $110K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 11,451 | 8,620 | $107K |
| 84484 | 7,936 | 4,607 | $106K | |
| 71045 | Radiologic examination, chest; single view | 9,041 | 7,415 | $105K |
| 36415 | Collection of venous blood by venipuncture | 57,667 | 40,673 | $92K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2,400 | 2,245 | $85K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,449 | 401 | $73K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,658 | 1,288 | $71K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,049 | 1,759 | $69K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,965 | 2,360 | $67K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 46 | 26 | $62K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 11,542 | 7,655 | $54K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 315 | 295 | $52K |
| 70450 | Computed tomography, head or brain; without contrast material | 888 | 709 | $50K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4,157 | 3,849 | $48K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,126 | 2,328 | $37K |
| 71046 | Radiologic examination, chest; 2 views | 1,734 | 1,587 | $34K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,521 | 1,411 | $32K |
| 99215 | Prolong outpt/office vis | 889 | 622 | $27K |
| 83735 | 6,151 | 4,509 | $27K | |
| 81025 | 6,422 | 5,805 | $26K | |
| 81003 | 22,638 | 18,910 | $21K | |
| 83690 | 2,814 | 2,316 | $16K | |
| 82728 | 5,391 | 3,645 | $15K | |
| 87807 | 1,272 | 1,238 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 8,843 | 6,233 | $12K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 198 | 178 | $11K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 156 | 127 | $11K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 145 | 127 | $11K |
| 83550 | 5,142 | 3,456 | $10K | |
| 83540 | 5,149 | 3,456 | $7K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 26 | 25 | $7K |
| 83605 | 808 | 598 | $5K | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 476 | 394 | $4K |
| 82607 | 2,352 | 1,601 | $4K | |
| 83880 | 312 | 250 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 794 | 657 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,867 | 2,311 | $3K |
| 82746 | 2,356 | 1,616 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 324 | 260 | $3K |
| 96367 | 130 | 73 | $2K | |
| 85027 | 494 | 422 | $2K | |
| 87040 | 201 | 105 | $2K | |
| 83615 | 3,098 | 1,893 | $2K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 30 | 24 | $2K |
| 96417 | 35 | 24 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,328 | 987 | $1K |
| 84703 | 155 | 134 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | 120 | 88 | $1K |
| 85379 | 106 | 92 | $962.71 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 841 | 527 | $955.16 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 107 | 93 | $819.85 |
| 0031A | 19 | 19 | $704.00 | |
| 96376 | 72 | 27 | $678.55 | |
| 84100 | 1,136 | 682 | $666.96 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 24 | 14 | $600.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 33 | 31 | $575.07 |
| 84702 | 16 | 14 | $372.19 | |
| 82150 | 66 | 52 | $297.44 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 606 | 454 | $256.17 |
| 84132 | 19 | 13 | $224.98 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 45 | 36 | $185.04 |
| 36416 | 106 | 72 | $140.00 | |
| 82378 | 110 | 68 | $115.93 | |
| 86300 | 160 | 76 | $112.02 | |
| 99442 | 17 | 12 | $106.91 | |
| 85652 | 72 | 51 | $95.66 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 134 | 117 | $91.39 |
| 80061 | Lipid panel | 28 | 28 | $90.23 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 210 | 126 | $85.86 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 102 | 93 | $85.05 |
| 73610 | 13 | 12 | $82.77 | |
| 87210 | 19 | 12 | $71.29 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 30 | 24 | $60.91 |
| 86140 | 71 | 50 | $59.56 | |
| 81001 | 44 | 40 | $52.00 | |
| 85610 | 34 | 29 | $41.73 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,427 | 1,973 | $21.42 |
| J7050 | Infusion, normal saline solution, 250 cc | 145 | 64 | $20.14 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 25 | 13 | $2.16 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 5,525 | 4,536 | $1.85 |
| 91303 | 19 | 19 | $0.03 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 777 | 672 | $0.02 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 17 | 12 | $0.00 |
| A9270 | Non-covered item or service | 3,455 | 2,436 | $0.00 |
| 84238 | 100 | 68 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 274 | 221 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 96 | 77 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 85 | 66 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 22 | 13 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,217 | 2,643 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 823 | 595 | $0.00 |
| 85045 | 44 | 25 | $0.00 | |
| 84439 | 17 | 13 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 16 | 15 | $0.00 |